ABM Therapeutics Shanghai Company Limited
2 clinical trials · Sponsor
◉ Watch ABM Therapeutics Shanghai Company Limited
| Record | Firm | Date |
|---|---|---|
| A Study of ABM-1310 in Patients With BRAF V600-Mutant Relapsed and Drug Resistant Primary Malignant Brain Tumors (NCT05892653) | ABM Therapeutics Shanghai Company Limited | 2023-06-30 |
| A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors (NCT05501912) | ABM Therapeutics Shanghai Company Limited | 2022-09-01 |
Track ABM Therapeutics Shanghai Company Limited automatically
Every clearance here is in the API, with alerts when new ones post.